$TCRG
Cannaisseur Group Inc. Stock $tcrg

$tcrg Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000118518524000527 Filed on May 15, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q4
Revenue	$0.00	$415.00
YoY Change	-100.0%	-97.48%
Cost Of Revenue	$485.00	$2.009K
YoY Change	-89.84%	-79.57%
Gross Profit	-$485.00	-$1.594K
YoY Change	-103.4%	-124.05%
Gross Profit Margin		-384.1%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization		$0.00
YoY Change		-100.0%
% of Gross Profit
Operating Expenses	$1.070M	$84.20K
YoY Change	1748.41%	120.55%
Operating Profit	-$1.070M	-$85.79K
YoY Change	2354.9%	171.94%
Interest Expense		$1.540K
YoY Change		81.82%
% of Operating Profit
Other Income/Expense, Net	-$1.560K	-$1.540K
YoY Change	511.76%	81.82%
Pretax Income	-$1.072M	-$87.33K
YoY Change	2344.18%	169.59%
Income Tax	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$1.071M	-$85.41K
YoY Change	2343.35%	416.97%
Net Earnings / Revenue		-20580.24%
Basic Earnings Per Share	-$0.02	$0.00
Diluted Earnings Per Share	-$0.02	$0.00
COMMON SHARES
Basic Shares Outstanding	42.55M shares	42.55M shares	40.58M shares
Diluted Shares Outstanding	44.95M shares	42.55M shares

Balance Sheet

Concept	2024 Q2	2024 Q1	2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$1.471K	$21.91K	$38.39K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory	$2.809K	$3.294K	$5.303K
Prepaid Expenses
Receivables			$0.00
Other Receivables
Total Short-Term Assets	$4.280K	$25.20K	$43.69K
YoY Change			22.06%
LONG-TERM ASSETS
Property, Plant & Equipment			$0.00
YoY Change			-100.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$0.00	$0.00	$0.00
YoY Change			-100.0%
TOTAL ASSETS
Total Short-Term Assets	$4.280K	$25.20K	$43.69K
Total Long-Term Assets	$0.00	$0.00	$0.00
Total Assets	$4.280K	$25.20K	$43.69K
YoY Change			-26.31%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due	$6.374K	$6.214K	$6.377K
YoY Change			320.37%
Total Short-Term Liabilities	$98.44K	$68.58K	$70.90K
YoY Change			26.76%
LONG-TERM LIABILITIES
Long-Term Debt	$105.8K	$105.9K	$65.78K
YoY Change			155.14%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$105.8K	$105.9K	$65.78K
YoY Change			155.14%
TOTAL LIABILITIES
Total Short-Term Liabilities	$98.44K	$68.58K	$70.90K
Total Long-Term Liabilities	$105.8K	$105.9K	$65.78K
Total Liabilities	$204.2K	$174.5K	$136.7K
YoY Change			67.27%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.602M	-$530.9K	-$445.5K
YoY Change			40.32%
Common Stock	$4.421K	$4.254K	$4.254K
YoY Change			14.35%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity
YoY Change
Total Liabilities & Shareholders Equity	$4.280K	$25.20K	$43.69K
YoY Change			-26.31%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2023 Q4
OPERATING ACTIVITIES
Net Income	-$1.071M	-$85.41K
YoY Change	2343.35%	416.97%
Depreciation, Depletion And Amortization		$0.00
YoY Change		-100.0%
Cash From Operating Activities		-$57.48K
YoY Change		60.46%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$0.00	$14.51K
YoY Change		-100.0%	-27.45%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		$41.00K
YoY Change		84.15%
NET CHANGE
Cash From Operating Activities		-$57.48K
Cash From Investing Activities
Cash From Financing Activities		$41.00K
Net Change In Cash		-$16.48K
YoY Change		21.56%
FREE CASH FLOW
Cash From Operating Activities		-$57.48K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity File Number EntityFileNumber	333-262710
CY2024Q1	dei	Entity Registrant Name EntityRegistrantName	The Cannaisseur Group, Inc.
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Atlanta
CY2024Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	GA
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	30308
CY2024Q1	dei	City Area Code CityAreaCode	404
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	254-2100
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2024Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	42547484	shares
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	21909	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	38390	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	3294	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	5303	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	25203	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	43693	usd
CY2024Q1	us-gaap	Assets Assets	25203	usd
CY2023Q4	us-gaap	Assets Assets	43693	usd
CY2024Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	48758	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	47918	usd
CY2024Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	12001	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	15001	usd
CY2024Q1	us-gaap	Dividends Payable Current DividendsPayableCurrent	1608	usd
CY2023Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	1608	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	68581	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	70904	usd
CY2024Q1	us-gaap	Long Term Notes Payable LongTermNotesPayable	25946	usd
CY2023Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	25783	usd
CY2024Q1	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	80000	usd
CY2023Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	40000	usd
CY2024Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	105946	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	65783	usd
CY2024Q1	us-gaap	Liabilities Liabilities	174527	usd
CY2023Q4	us-gaap	Liabilities Liabilities	136687	usd
CY2024Q1	us-gaap	Redeemable Noncontrolling Interest Equity Preferred Carrying Amount RedeemableNoncontrollingInterestEquityPreferredCarryingAmount	37875	usd
CY2023Q4	us-gaap	Redeemable Noncontrolling Interest Equity Preferred Carrying Amount RedeemableNoncontrollingInterestEquityPreferredCarryingAmount	37875	usd
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	42547484	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	42547484	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	42547484	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	42547484	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	4254	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	4254	usd
CY2024Q1	tcgi	Common Stock To Be Issued CommonStockToBeIssued	200	usd
CY2023Q4	tcgi	Common Stock To Be Issued CommonStockToBeIssued	0	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	445583	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	414783	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-530946	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-445538	usd
CY2024Q1	us-gaap	Minority Interest MinorityInterest	-106290	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	-104368	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-187199	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-130869	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	25203	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	43693	usd
CY2024Q1	us-gaap	Revenues Revenues	415	usd
CY2023Q1	us-gaap	Revenues Revenues	16463	usd
CY2024Q1	us-gaap	Cost Of Revenue CostOfRevenue	2009	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	9835	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	-1594	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	6628	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	84196	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	38175	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	84196	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	38175	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-85790	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-31547	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	1540	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	847	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1540	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-847	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-87330	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-32394	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-87330	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-32394	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1922	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-15873	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-85408	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-16521	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	42547484	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	37315025	shares
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-13558	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	38390	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18534	usd
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	42547484	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	37315025	shares
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-60303	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	10000	usd
CY2023Q1	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital	10482	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-32394	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-72215	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-130869	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	30000	usd
CY2024Q1	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital	1000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-87330	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-187199	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-87330	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-32394	usd
CY2024Q1	us-gaap	Depreciation Depreciation	0	usd
CY2023Q1	us-gaap	Depreciation Depreciation	786	usd
CY2024Q1	us-gaap	Amortization Of Leased Asset AmortizationOfLeasedAsset	0	usd
CY2023Q1	us-gaap	Amortization Of Leased Asset AmortizationOfLeasedAsset	5020	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	30000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	0	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	0	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-807	usd
CY2024Q1	us-gaap	Increase Decrease Due From Affiliates IncreaseDecreaseDueFromAffiliates	0	usd
CY2023Q1	us-gaap	Increase Decrease Due From Affiliates IncreaseDecreaseDueFromAffiliates	0	usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-2009	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	171	usd
CY2024Q1	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	0	usd
CY2023Q1	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	-6084	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	840	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1779	usd
CY2024Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-3000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	0	usd
CY2024Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	0	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-5566	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-57481	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-35823	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	10000	usd
CY2024Q1	us-gaap	Proceeds From Other Short Term Debt ProceedsFromOtherShortTermDebt	0	usd
CY2023Q1	us-gaap	Proceeds From Other Short Term Debt ProceedsFromOtherShortTermDebt	4095	usd
CY2024Q1	us-gaap	Repayments Of Other Short Term Debt RepaymentsOfOtherShortTermDebt	0	usd
CY2023Q1	us-gaap	Repayments Of Other Short Term Debt RepaymentsOfOtherShortTermDebt	1362	usd
CY2024Q1	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital	1000	usd
CY2023Q1	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital	10482	usd
CY2024Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	40000	usd
CY2023Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	usd
CY2024Q1	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	0	usd
CY2023Q1	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-950	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	41000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	22265	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-16481	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	21909	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4976	usd
CY2024Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><span style="text-decoration:underline">Concentration of Risk</span></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company may periodically contract with consultants and vendors to provide services related to the Company's business development activities. Agreements for these services may be for a specific time period or for a specific project or task. The Company did not have any agreements at March 31, 2024 or December 31, 2023.</p>
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	200	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	670	usd
CY2024Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2023Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-530946	usd
CY2024Q1	tcgi	Working Capital Deficit WorkingCapitalDeficit	-43541	usd
CY2021Q1	tcgi	Ownership Percentage OwnershipPercentage	0.38	pure
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><span style="text-decoration:underline">Use of Estimates</span></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Management bases its estimates on historical experience and on various assumptions that are believed to be reasonable in relation to the financial statements taken as a whole under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Management regularly evaluates the key factors and assumptions used to develop the estimates utilizing currently available information, changes in facts and circumstances, historical experience and reasonable assumptions. After such evaluations, if deemed appropriate, those estimates are adjusted accordingly. Actual results could differ from those estimates. Significant estimates are expected to include those related to assumptions used in calculating accruals for potential liabilities, valuing equity instruments issued for services, and the realization of deferred tax assets.</p>
CY2024Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3183400	shares
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2666667	shares
CY2024Q1	us-gaap	Loans Payable LoansPayable	4860	usd
CY2023Q4	us-gaap	Loans Payable LoansPayable	4860	usd
CY2024Q1	us-gaap	Notes Payable NotesPayable	27300	usd
CY2023Q4	us-gaap	Notes Payable NotesPayable	27300	usd
CY2024Q1	us-gaap	Long Term Debt LongTermDebt	112160	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	72160	usd
CY2024Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	6214	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	6377	usd
CY2024Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	105946	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	65783	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	6214	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	80646	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	671	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	696	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	723	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	23210	usd
CY2024Q1	us-gaap	Long Term Debt LongTermDebt	112160	usd
CY2023Q4	tcgi	Operating Lease Right Of Use Asset Before Accumulated Amortization OperatingLeaseRightOfUseAssetBeforeAccumulatedAmortization	84994	usd
CY2023Q4	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.10	pure
CY2023Q4	us-gaap	Security Deposit SecurityDeposit	9084	usd
CY2023Q4	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	18000	usd
CY2023Q4	us-gaap	Loss Contingency Settlement Agreement Terms LossContingencySettlementAgreementTerms	monthly installments of $1,500 for 12 months
CY2023	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	4185	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	2726	usd
CY2023	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	18968	usd
CY2024Q1	us-gaap	Payments For Rent PaymentsForRent	3000	usd
CY2024Q1	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	12001	usd
CY2023Q4	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	15001	usd
CY2024Q1	us-gaap	Temporary Equity Description TemporaryEquityDescription	preferred stock of Atlanta CBD with redeemable features that allow the investors (“Investors”) to request repayment of their investment. The Investors are also entitled to profit distributions equal to the lesser of (i) 25% interest, (ii) the difference between the ownership percentage of management and 50%, which will be distributed to management, until a 35% profit goal achieved. Preferred shareholders are entitled to a return of their investment upon 15 days’ notice given to the Company after any distribution
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	42547484	shares
CY2023Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	333334	shares
CY2023Q4	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	9084	usd
CY2023Q4	us-gaap	Litigation Settlement Amount Awarded To Other Party LitigationSettlementAmountAwardedToOtherParty	18000	usd
CY2023Q4	us-gaap	Loss Contingency Settlement Agreement Terms LossContingencySettlementAgreementTerms	monthly installments of $1,500 for 12 months
CY2023	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	18968	usd
CY2024Q1	us-gaap	Payments For Rent PaymentsForRent	3000	usd
CY2024Q1	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	12001	usd
CY2023Q4	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	15001	usd
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001879270

Files In Submission

Name	View Source	Status
0001185185-24-000527-index-headers.html	Edgar Link	pending
0001185185-24-000527-index.html	Edgar Link	pending
0001185185-24-000527.txt	Edgar Link	pending
0001185185-24-000527-xbrl.zip	Edgar Link	pending
ex_671805.htm	Edgar Link	pending
ex_671806.htm	Edgar Link	pending
ex_671807.htm	Edgar Link	pending
ex_671808.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
tcgi-20240331.xsd	Edgar Link	pending
tcgi20240331_10q.htm	Edgar Link	pending
tcgi-20240331_def.xml	Edgar Link	unprocessable
tcgi-20240331_lab.xml	Edgar Link	unprocessable
tcgi-20240331_pre.xml	Edgar Link	unprocessable
tcgi20240331_10q_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable
tcgi-20240331_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$TCRG
Cannaisseur Group Inc. Stock $tcrg

2024 Q2 Form 10-Q Financial Statement

#000118518524000527 Filed on May 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TCRG Cannaisseur Group Inc. Stock $tcrg

2024 Q2 Form 10-Q Financial Statement

#000118518524000527 Filed on May 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TCRG
Cannaisseur Group Inc. Stock $tcrg